Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis

Frontiers in Oncology

Oncology

Yi-fen Wu¹  Hiu Yee Kwan²  Jie Zhou³  Xing-hong Zhou³  Xiao-shan Zhao³  Yan-yan Liu³  Yan Liu³  Si-qi Wu³  Yan-ting You³  Li-qian Chen³ 

[1] Department of Oncology, Affiliated Dongguan People’s Hospital, Southern Medical University, Dongguan, Guangdong, China;School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China;School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China;

关键词: breast cancer;    brain metastasis;    bibliometric analysis;    research trend;    TKI (tyrosine kinase inhibitor);    ADC (antibody-drug conjugate);   

DOI  :  10.3389/fonc.2023.1091249

 received in 2022-11-21, accepted in 2023-03-13,  发布年份 2023

来源: Frontiers

【 摘 要 】

IntroductionBrain metastasis is the terminal event of breast cancer with poor prognoses. Therefore, this article aimed to provide an updated summary on the development, hotspots, and research trends of brain metastasis from breast cancer based on bibliometric analysis.MethodPublications on breast cancer with brain metastasis retrieved from the Web of Science Core Collection. CiteSpace, VOSviewer, and other online bibliometric analysis platforms were used to analyze and visualize the result.ResultIn totality, 693 researchers from 3,623 institutions across 74 counties and regions published a total of 2,790 papers in 607 journals. There was a noticeable increase in publications in 2006. The United States was the dominant country with the most publications followed by China. University Texas MD Anderson Cancer Center was the most productive institution, while Dana Farber Cancer Institution was the most cited. Journal of Neuro-Oncology published the most papers, while Journal of Clinical Oncology ranked first based on cocited analysis. Nancy U. Lin was the most productive and cited author with high influence. There was a focus on basic research, clinical trials, local therapy, treatment optimization, and epidemiological studies regarding brain metastases from breast cancer. References focused on pathogenesis, prevention, treatment, and prognosis were cited most frequently, among which the clinical trial of novel treatment attracted most attention from researchers. Reference citation burst detection suggested that new therapies such as the novel tyrosine kinase inhibitor and antibody–drug conjugate may lead the research trends in the future.ConclusionHigh-income countries contributed more to the field of breast cancer with brain metastasis, while developing countries like China developed quickly. Furthermore, the success of novel therapies in recent years may lead to the new era of treatment of breast cancer with brain metastasis in the future.

【 授权许可】

Unknown   
Copyright © 2023 Wu, Liu, Zhou, You, Zhou, Chen, Kwan, Zhao, Wu and Liu